Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced ...
News-Medical.Net on MSN
Struggling to make ends meet may slow brain development in infants
Researchers identify specific psychosocial factors that strongly correlate with altered brain development within the first ...
According to the paper, artificial intelligence addresses a core weakness in Parkinson’s care: reliance on subjective ...
Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant ...
LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...
LumiSleep uses real-time EEG and adaptive sound to ease the transition into sleep, offering a more personalized alternative ...
FITBOOK magazine on MSN
Researchers Can Predict Risk for 1,000 Diseases Based on Sleep
Could our nightly sleep provide hidden clues to serious illnesses—years before symptoms appear? And could artificial ...
The American Medical Association (AMA) has announced the recipients of $12 million in grant funding aimed at accelerating ...
The randomized, double-blind, sham-controlled trial evaluated 56 adults with ADHD who received four weeks of Nexalin’s ...
Wearable health devices now track heart health, stress, glucose, fertility, and sleep, turning smart wearables into everyday ...
In 2025, Google’s YouTube made several major upgrades, some of which frustrated users and some of which pleased them. In a ...
These are tech expert Marc Salzman's top CES picks for USA TODAY after his hands-on with future gadgets and gear in Las Vegas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback